DR.REDDY'S LABORATORIES LTD. - 500124 - Board Meeting Intimation for Consideration And Approval Of The Unaudited Financial Results Of The Company For The Quarter Ending On June 30, 2023.
DR.REDDY''s LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/07/2023 ,inter alia, to consider and approve Consideration and approval of the Unaudited Financial Results of the Company for the quarter ending on June 30, 2023.
Dr Reddy Share Price Live blog for 21 Jun 2023
Dr Reddy stock price went up today, 21 Jun 2023, by 0.8 %. The stock closed at 4873.5 per share. The stock is currently trading at 4912.5 per share. Investors should monitor Dr Reddy stock price closely in the coming days and weeks to see how it reacts to the news. Dr Reddy Share Price Live blog for 20 Jun 2023
Dr Reddy stock price went down today, 20 Jun 2023, by -0.88 %. The stock closed at 4916.75 per share. The stock is currently trading at 4873.5 per share. Investors should monitor Dr Reddy stock price closely in the coming days and weeks to see how it reacts to the news. DR.REDDY'S LABORATORIES LTD. - 500124 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper ad for TDS communication on dividend payout
Dr Reddy's hits 52-week high on US FDA all-clear to API unit
Dr Reddy's formulations manufacturing facility in Srikakulam, however, was issued an Establishment Inspection Report by the FDA, with Voluntary Action Indicated classification Dr Reddy Share Price Live blog for 19 Jun 2023
Dr Reddy stock price went up today, 19 Jun 2023, by 2.33 %. The stock closed at 4804.75 per share. The stock is currently trading at 4916.75 per share. Investors should monitor Dr Reddy stock price closely in the coming days and weeks to see how it reacts to the news. USFDA completes inspection at Dr Reddy's with zero observations
The inspection at Dr Reddy's facilities concluded with zero observations, and the USFDA has classified the inspection as Voluntary Action Indicated, indicating a positive outcome. DR.REDDY'S LABORATORIES LTD. - 500124 - Intimation Regarding CTO 3 And FTO SEZ PU2
Intimation regarding: a) completion of GMP inspection by USFDA of our API facility at Bollaram (CTO3) with zero observations and b) receipt of EIR for closure of the USFDA inspection conducted at FTO SEZ PU2 DR.REDDY'S LABORATORIES LTD. - 500124 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of Loss of Share certificate(s) Dr Reddy Share Price Live blog for 16 Jun 2023
Dr Reddy stock price went up today, 16 Jun 2023, by 2.48 %. The stock closed at 4694.45 per share. The stock is currently trading at 4810.7 per share. Investors should monitor Dr Reddy stock price closely in the coming days and weeks to see how it reacts to the news.